Inferior vena cava filters 의 안전성 경고

Department of Health에 따르면, 해당 안전성 경고 는 Hong Kong 에서 N/A 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 날짜
    2016-07-26
  • 사례 출판 날짜
    2016-07-26
  • 사례 국가
  • 사례 출처
    DH
  • 사례 출처 URL
  • 비고 / 경고
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • 데이터 추가 비고
    Medical Device Safety Alert
  • 원인
    Medical device safety alert: inferior vena cava filters the health canada has issued a medical device alert concerning inferior vena cava (ivc) filters. the manufacturers, models and categories of the affected devices are as follows: manufacturermodelcategory ‧a.L.Naln vena cava filterretrievable ‧bard peripheral vasculardenali vena cava filterg2 filter systemsimon nitinol vena cava filterretrievableretrievablepermanent ‧b. braun medicalvenatech lp vena cava filter systempermanent ‧cordis casheloptease vena cava filtertrapease permanent vena cava filterretrievablepermanent ‧rex medical, lpoption retrievable vena cava filter systemretrievable ‧william cook, europe aps and cook, inc.Cook celect platinum vena cava filtercook celect vena cava filtergianturco-roehm birds nest vena cava filtergunther tulip vena cava mreye filter setretrievableretrievablepermanentretrievable as of june 6, 2016, health canada has received 121 incident reports of serious complications associated with ivc filters. these complications have also been reported internationally. serious complications such as caval perforation, caval thrombosis, filter fracture and fragment embolization, intracardiac migration, cardiac perforation, cardiac tamponade, and death have been reported in patients who have been implanted with ivc filters. many of these complications occurred with long-term (greater than 30 days) filter implantation. health canada has recently completed a review of the clinical evidence for the safety and effectiveness of ivc filters. although there have been numerous clinical studies of ivc filters, there are only two randomized controlled trials (rcts) of ivc filter use. in both studies, patients with documented venous thrombo-embolism (vte) were randomized to therapeutic anticoagulation alone or to therapeutic anticoagulation plus an ivc filter. results from these two rcts do not support the use of ivc filters in patients who can be treated with anticoagulation. reductions in vte and mortality have not been demonstrated. health canada is communicating to healthcare professionals that ivc filters are appropriate for patients with certain types of blood clots, who cannot be treated with anticoagulant drugs. health canada is also working with the manufacturers of ivc filters to continue to monitor the post-market safety and effectiveness of ivc filters in canada as well as worldwide. for details, please visit the following health canada website: http://healthycanadians.Gc.Ca/recall-alert-rappel-avis/hc-sc/2016/59518a-eng.Php posted on 26 july 2016.

Device

  • 모델명 / 제조번호(시리얼번호)
  • 제품 설명
    Medical Device Safety Alert: Inferior vena cava filters
  • Manufacturer
    N/A

Manufacturer

N/A
  • Source
    DH